Pfizer concludes sale of PAPPL to PAHIL

10 Dec 2012 Evaluate

Pfizer has completed the sale of entire equity stake of its wholly owned subsidiary Pfizer Animal Pharma (PAPPL) to Pfizer Animal Health India (PAHIL), a 100% indirect subsidiary of Pfizer Inc., USA. The company has received the consideration amount of Rs 471.60 crore for the same from PAHIL.

Earlier, Pfizer had received board approval which was held on November 08, 2012 for sale of PAPPL to PAHIL for a consideration of Rs 471.60 crore.

Pfizer manufactures prescription drugs such as Viagra, Lyrica, Viagra, Dolonex Gel, Ponstan, Citralka Liquid, and many more. Its first production unit was set up at Darukhanna in Mumbai.

Pfizer Share Price

5222.05 92.95 (1.81%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.